FDA Warns Consumers Against Using 26 Eye Drop Products Due to Infection Risk Background and Context The U.S. Food and Drug Administration (FDA) has issued a warning to consumers to stop using 26 over-the-counter eye drop products due to a potential risk of infection. These products are marketed under various store brands, including CVS Health, […]
The FDA Approves Opill: A Landmark Event in Birth Control Access Introduction In a landmark decision, the Food and Drug Administration (FDA) has approved Opill, the first daily oral contraceptive pill available over the counter in the United States. This approval comes at a crucial time when certain states have been attempting to restrict access […]
FDA Advisers Approve Over-the-Counter Birth Control Pill A Landmark Decision for Women’s Empowerment The US Food and Drug Administration (FDA) made a historic decision on Thursday, approving the birth control pill Opill to be sold over-the-counter. This marks the first time a nonprescription birth control pill is available in the United States. Dr. Patrizia Cavazzoni, […]
Sen. Schumer Calls on FDA to Investigate PRIME Energy Drink On Sunday, Senator Charles Schumer of New York called on the Food and Drug Administration (FDA) to investigate PRIME, an energy drink brand founded by YouTube stars Logan Paul and KSI. Schumer also urged the FDA to issue warnings to parents regarding the high caffeine […]
The Approval of Alzheimer’s Drug Leqembi and Its Implications F.D.A. Approval and Medicare Coverage The Food and Drug Administration (FDA) recently granted full approval to the Alzheimer’s drug Leqembi, marking the first time in two decades that a drug for the disease has received such approval. Despite the approval, however, the FDA also imposed a […]
FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval The U.S. Food and Drug Administration (FDA) has made the decision to convert Leqembi (lecanemab-irmb), a novel treatment for Alzheimer’s Disease, from accelerated approval to traditional approval. This conversion comes after a confirmatory trial verified the clinical benefit of the drug. Leqembi is the first amyloid […]
